News for Hepion Pharmaceuticals, Inc. (336P.F)

Gainers Cuentas Inc. (NASDAQ:CUEN) shares rose 72.6% to $6.48 in pre-market trading. Cuentas, earlier during the month, priced upsized 2.79 mill...

Some of the stocks that may grab investor focus today are: Wall Street expects CVS Health Corp (NYSE: CVS) to report quarterly earnings at $1.24 per share ...

Former Novo Nordisk Executive, Dr. Todd M. Hobbs, Joins Hepion Pharmaceuticals as Chief Medical Officer February 10, 2021 EDISON, NJ / ACCESSWIRE / February 10, 2021 /... | February 10, 2021

NEW YORK and LONDON, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA / LSE: TILS) ('Tiziana' or the 'Company'), a biot...

Our AI-Driven Bioinformatics Platform is Expected to Accelerate the Development of a Novel NASH Therapeutic and Create Pathways to Optimize Efficacy ... | January 28, 2021